NASDAQ:RCEL - AVITA Medical Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $38.75
  • Forecasted Upside: 80.65 %
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$21.45
▲ +0.24 (1.13%)

This chart shows the closing price for RCEL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New AVITA Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RCEL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RCEL

Analyst Price Target is $38.75
▲ +80.65% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for AVITA Medical in the last 3 months. The average price target is $38.75, with a high forecast of $45.00 and a low forecast of $27.00. The average price target represents a 80.65% upside from the last price of $21.45.

This chart shows the closing price for RCEL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 4 polled investment analysts is to buy stock in AVITA Medical.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/1/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/31/2020
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/29/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
9/27/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/26/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/26/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/25/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/24/2021

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/12/2021BTIG ResearchReiterated RatingBuy$41.00Medium
3/2/2021Piper SandlerInitiated CoverageOverweight$27.00High
8/30/2020OppenheimerReiterated RatingBuy$45.00Low
8/27/2020Bank of AmericaInitiated CoverageBuy$42.00High
7/9/2020BTIG ResearchBoost Price TargetBuy$8.00 ➝ $41.00High
7/6/2020OppenheimerBoost Price TargetOutperform$9.00 ➝ $45.00Low
6/18/2020BTIG ResearchReiterated RatingBuy$8.00Medium
6/15/2020OppenheimerInitiated CoverageBuy$9.00High
4/20/2020OppenheimerInitiated CoverageOutperform$9.00High
4/6/2020BTIG ResearchReiterated RatingBuy$8.00High
3/5/2020Lake Street CapitalReiterated RatingBuy$12.00High
3/3/2020BTIG ResearchInitiated CoverageBuy$10.00High
10/31/2019Lake Street CapitalBoost Price TargetBuy$10.00 ➝ $12.00Low
(Data available from 6/24/2016 forward)
AVITA Medical logo
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish and explore development of a spray-on treatment for patients with epidermolysis bullosa; and a research collaboration with Houston Methodist Research Institute to explore novel approaches for skin rejuvenation. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. is based in Valencia, California.
Read More

Today's Range

Now: $21.45
Low: $21.08
High: $22.03

50 Day Range

MA: $19.35
Low: $17.23
High: $21.86

52 Week Range

Now: $21.45
Low: $16.87
High: $30.93

Volume

236,853 shs

Average Volume

157,265 shs

Market Capitalization

$532.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of AVITA Medical?

The following Wall Street analysts have issued research reports on AVITA Medical in the last year: Bank of America Co., BTIG Research, Oppenheimer Holdings Inc., Piper Sandler, and Zacks Investment Research.
View the latest analyst ratings for RCEL.

What is the current price target for AVITA Medical?

4 Wall Street analysts have set twelve-month price targets for AVITA Medical in the last year. Their average twelve-month price target is $38.75, suggesting a possible upside of 82.7%. Oppenheimer Holdings Inc. has the highest price target set, predicting RCEL will reach $45.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $27.00 for AVITA Medical in the next year.
View the latest price targets for RCEL.

What is the current consensus analyst rating for AVITA Medical?

AVITA Medical currently has 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe RCEL will outperform the market and that investors should add to their positions of AVITA Medical.
View the latest ratings for RCEL.

What other companies compete with AVITA Medical?

How do I contact AVITA Medical's investor relations team?

AVITA Medical's physical mailing address is 28159 Avenue Stanford Suite 220, Valencia CA, 91355. The company's listed phone number is 661-367-9170 and its investor relations email address is [email protected] The official website for AVITA Medical is www.avitamedical.com.